Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005116-41Phase 4Active
Phase 4, randomised, double-blind trial in obesity and neuromuscular block (NMB) comparing Sugammadex arm with Neostigmine arm (2 arms). Primary endpoint: Timing of reversal from neuromuscular blockade. Started Apr 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005116-41.